Zenker's Diverticulum: Carbon Dioxide Laser Endoscopic Surgery

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10283134" target="_blank" >RIV/00216208:11110/14:10283134 - isvavai.cz</a>

Alternative codes found

RIV/00064203:_____/14:10283134

Result on the web

<a href="http://dx.doi.org/10.1155/2014/516231" target="_blank" >http://dx.doi.org/10.1155/2014/516231</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1155/2014/516231" target="_blank" >10.1155/2014/516231</a>

Result language

angličtina

Original language name

Zenker's Diverticulum: Carbon Dioxide Laser Endoscopic Surgery

Original language description

Nowadays endoscopic diverticulotomy is the surgical approach of the first choice in treatment of Zenker's diverticulum. We report our experience with this procedure and try to sum up recent recommendations for management of surgery and postoperative care. Data of 34 patients with Zenker's diverticulum, treated by endoscopic carbon dioxide laser diverticulotomy at the Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic, were prospectively stored and followed in relatively short period from May 2009 to December 2013. The average length of diverticulum was 32 mm. The average duration of surgery was 32 min. The patients were fed via feeding tube for 6.1days and antibiotics were administered for 7 days. Mean hospitalization time was 7.4 days. We observed one transient recurrent laryngeal nerve paralysis and no other serious complications. Recurrence rate was 3%. We recommend complete tra

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry

OECD FORD branch

—

Project

<a href="/en/project/NT13488" target="_blank" >NT13488: Genomic analysis of tumor-associated fibroblasts in head and neck carcinoma: The basis for new generation of biologic anti-tumor therapy</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2014

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

BioMed Research International

ISSN

2314-6133

e-ISSN

—

Volume of the periodical

neuveden

Issue of the periodical within the volume

March

Country of publishing house

US - UNITED STATES

Number of pages

5

Pages from-to

—

UT code for WoS article

000332896400001

EID of the result in the Scopus database

—